Gilead Sciences GILD recently announced that it has exercised its combined option to exclusively license Assembly Biosciences’ ASMB herpes simplex virus (HSV) helicase-primase inhibitor programs. The ...

Emu NL ( (AU:EMU)) has provided an update. Emu NL has reported that its ongoing reverse circulation drilling program at the Fiery Creek prospect in North Queensland has intersected visible primary ...

Members of American Airlines' loyalty program will no longer earn miles or other travel rewards when purchasing a basic economy ticket. People enrolled in the carrier's AAdvantage program previously ...

Gilead Sciences, Inc. (Nasdaq: GILD) and Assembly Biosciences, Inc. (Nasdaq: ASMB), today announced Gilead has exercised its combined option to exclusively license Assembly Bio’s herpes simplex virus ...

・Gilead will advance the clinical development and commercialization of the programs and Assembly Bio will receive a $35 million payment for Gilead’s exercise of the combined HSV program option. ・H.C.

Liz Simmons is an education staff writer at Forbes Advisor. She has written about higher education and career development for various online publications since 2016. She earned a master’s degree in ...

In a note dated 27 February 2022, the Secretary-General informed Member States that the eleventh emergency special session would convene at Headquarters on Monday, 28 February 2022 for the ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...